Alcon Research
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Alcon Research sits in the top decile of US sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count).
Alcon Research: 275 sponsored US clinical trials, 5 recruiting.
Alcon Research sponsors 275 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 248 completed. 87 of these trials are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract, with 12 trials.
Top-decile sponsor footprint
Alcon Research ranks in the top decile of sponsors by registered trial count (#124 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
248 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
275 total, page 6 of 6
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
NCT00333255
Anecortave Acetate Risk-Reduction Trial (AART)
NCT00333216
Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)
NCT00299507
Effect of Multi-Purpose Solutions on Ex-Vivo Wetting Angles
NCT00383201
Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
NCT00333268
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients
NCT00382603
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact Lenses
NCT00382902
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact Lenses
NCT00382681
Anecortave Acetate Risk-Reduction Trial (AART)
NCT00307398
Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD
NCT00065728
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
NCT00061503
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
NCT00058994
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00061529
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension
NCT00061542
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT00051194
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
NCT00041483
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
NCT00047541
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT00051142
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
NCT00051155
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
NCT00047515
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41
NCT00047528
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
NCT00346866
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
NCT00047593
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
NCT00051181
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00069719
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 23 |
| Phase 3 | 47 |
| Phase 4 | 40 |
Therapeutic Areas
Where Alcon Research enrollment is open (later-stage tilt)
5 recruiting of 275 indexed (2% open); 248 completed (90%).
Phase mix: 87 late (III/IV) vs 28 early (I/II) (later-stage heavy).
Top condition: Cataract (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alcon Research: open-pipeline peers nationwide
Peers matched on 275 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Alcon Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 275 trials (± recruiting share)
- Boston Scientific Corporation · 280 trials · 8% recruiting
- Regeneron Pharmaceuticals · 280 trials · 22% recruiting
- SWOG Cancer Research Network · 270 trials · 10% recruiting
- Novartis · 265 trials · 0% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · 2% recruiting · 55 trials
- Lexicon Pharmaceuticals · 2% recruiting · 56 trials
- Société des Produits Nestlé (SPN) · 2% recruiting · 53 trials
- Eisai · 2% recruiting · 287 trials
Related
What to do with this Alcon Research page
275 registered trials is a research-attention snapshot, not an endorsement of Alcon Research or any single study.
- 5 of Alcon Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cataract is the condition Alcon Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Alcon Research pipeline card: 275 registered trials from official public datasets.Report a data error.